FR901464 is a natural product isolated from Pseudomonas species, characterized by a spiro-epoxide structure and recognized for its potent anticancer activity. It functions by reducing the mRNA levels of oncogenes and tumor suppressor genes and also exhibits antimicrobial properties.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 146478-72-0
Spliceostatin A
Spliceostatin A intermediate
(2Z,4S)-4-(Acetyloxy)-N-((2R,3R,5S,6S)-6-((2E,4E)-5-((2R,3R,4S,6S)-4-(chloromethyl)tetrahydro-3,4,6-trihydroxy-6-methyl-2H-pyran-2-yl)-3-methyl-2,4-pentadien-1-yl)tetrahydro-2,5-dimethyl-2H-pyran-3-yl)-2-pentenamide
n.a
(2S,3Z)-5-{[(2R,3R,5S,6S)-2,5-dimethyl-6-{(2E,4E)-3-methyl-5-[(3R,4R,5R,7S,8R)-4,7,8-trihydroxy-7-methyl-1,6-dioxaspiro[2.5]oct-5-yl]penta-2,4-dien-1-yl}tetrahydro-2H-pyran-3-yl]amino}-5-oxopent-3-en-2-yl acetate
antineoplastic agent
Thailanstatin A
pharmaceutical intermediate from Burkholderia thailandensis
DANTROLENE SODIUM
active pharmaceutical ingredient
Ziprasidone
active pharmaceutical ingredient
Tipepidine citrate
active pharmaceutical ingredient
Oxolinic acid
quinolone antibiotic active pharmaceutical ingredient
[(Z,2S)-5-[[(2R,3R,5S,6S)-6-[(2E,4E)-5-[(3R,4R,5R,7S)-4,7-dihydroxy-7-methyl-1,6-dioxaspiro[2.5]octan-5-yl]-3-methylpenta-2,4-dienyl]-2,5-dimethyloxan-3-yl]amino]-5-oxopent-3-en-2-yl] acetate
PJKVJJDQXZARCA-QHYZBLTGSA-N
C[C@H]1C[C@H]([C@H](O[C@H]1C/C=C(\C)/C=C/[C@@H]2[C@H]([C@@]3(C[C@@](O2)(C)O)CO3)O)C)NC(=O)/C=C\[C@H](C)OC(=O)C